Q: Please describe this drug.
Description: The Compound has the SMILES CNC(=O)c1cc(Cl)c(OC(C)(C)C(=O)O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2.
Answer: AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD).
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CNC(=O)c1cc(Cl)c(OC(C)(C)C(=O)O)cc1OC[C@@H](O)CN1CCC2(CC1)Cc1cc(Cl)ccc1O2
CC(C)(C(=O)O)OC1=C(C=C(C(=C1)OC[C@H](CN2CCC3(CC2)CC4=C(O3)C=CC(=C4)Cl)O)C(=O)NC)Cl
2-[2-chloro-5-[(2S)-3-(5-chlorospiro[3H-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-(methylcarbamoyl)phenoxy]-2-methylpropanoic acid
Please describe this drug.
AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD).